Design, synthesis, molecular modeling, and bioactivity evaluation of 1,10-phenanthroline and prodigiosin (Ps) derivatives and their Copper(I) complexes against mTOR and HDAC enzymes as highly potent…

Overview of attention for article published in Frontiers in Pharmacology, October 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 7,706 followers.

RT @mmcetin_chem: Our new article has just been published and it is online now at https://t.co/uM555v4Oio This article has been dedicated…

25 Oct 2022

Reply Repost Favourite

New article: Design, synthesis, molecular modeling, and bioactivity evaluation of 1,10-phenanthroline and prodigiosin (Ps) derivatives and their Copper(I) complexes against mTOR and HDAC enzymes as highly potent and effective new… https://t.co/1Se5OLsjyg #

21 Oct 2022

Reply Repost Favourite

New Research: Design, synthesis, molecular modeling, and bioactivity evaluation of 1,10-phenanthroline and prodigiosin (Ps) derivatives and their Copper(I) complexes against mTOR and HDAC enzymes as highly potent and effective new… https://t.co/s9XVvXtc5B

05 Oct 2022

Reply Repost Favourite

Our new article has just been published and it is online now at https://t.co/uM555v4Oio This article has been dedicated to those who suffered and/or have been suffering from "BREAST CANCER or BREAST CANCER BRAIN METASTASIS" @khasedutr @TexasTech @sirfrase

04 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.